UNITED THERAPEUTICS Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · Silver Spring, MD
UTHR chart
What traders are saying about $UTHR
Latest postsUNITED THERAPEUTICS Corp news
- CEO trusts exercised $117.76 options and sold 9,500 shares in United Therapeutics (UTHR).
Stock Titan ·
- S&P 500 Futures Up in Premarket Trading; MSG Sports, United Therapeutics Lag
Barron's ·
- United Therapeutics Corporation (NASDAQ:UTHR) Gains 0.91% to USD 592.84
Kalkine India ·
- United Therapeutics CEO sells $5.5M in stock By Investing.com
Investing.com Nigeria ·
- Form 4 United Therapeutics Corporation: Martine A. Rothblatt (Director, Chairperson & CEO) For: 23 October
Investing.com Nigeria ·
- After exercising options at $117.76, United Therapeutics (UTHR) CEO trusts sell 9,500 shares.
Stock Titan ·
- Weekly Recap: UTHR $2B buyback approval and $330.4M LQDA settlement
TradingView ·
- Billionaire Martine Rothblatt Sells $5.5 Million in United Therapeutics Shares
CEOWORLD magazine ·
- United Therapeutics (NDQ:UNTR): The Only Company Attempting Xenotransplantation At Scale!
Stocks Down Under ·
- United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- U.S. transgender billionaire Martine Rothblatt sells $5.5 million in United Therapeutics stock
Billionaires.Africa ·
- United Therapeutics (UTHR) Opens Xeno Organ Production Sites In Houston And Stewartville
Simply Wall Street ·
UNITED THERAPEUTICS Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.18B | $2.88B | $2.33B | $1.94B |
| Net income | $1.33B | $1.20B | $984.8M | $727.3M |
| Diluted EPS | $27.86 | $24.64 | $19.81 | $15.00 |
| Total assets (year end) | $7.88B | $7.36B | $7.17B | $6.04B |
| Cash and equivalents (year end) | $1.56B | $1.70B | $1.21B | $961.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About UNITED THERAPEUTICS Corp
- Ticker
- UTHR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Silver Spring, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1082554
Frequently asked questions
What exchange is UNITED THERAPEUTICS Corp listed on?
UNITED THERAPEUTICS Corp trades on the Nasdaq under the ticker symbol UTHR.
What industry is UNITED THERAPEUTICS Corp in?
UNITED THERAPEUTICS Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is UNITED THERAPEUTICS Corp headquartered?
UNITED THERAPEUTICS Corp's business address on file with the SEC is in Silver Spring, MD.
When does UNITED THERAPEUTICS Corp's fiscal year end?
UNITED THERAPEUTICS Corp's fiscal year ends on December 31.
How much revenue did UNITED THERAPEUTICS Corp report?
UNITED THERAPEUTICS Corp reported $3.18B in revenue for calendar year 2025, according to its SEC filings.